Published in Genetics and Environmental Business Week, October 25th, 2007
"The current study used a double blind, crossover (methylphenidate vs placebo) design to assess DAT1 genotype differences on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.